3 Green Flags for Biotech Stocks in 2023 and Beyond

[admin]

Thanks to a confluence of favorable technological, scientific, and business factors, the industry could soon go into overdrive. Research and development for new drugs is difficult and expensive. As of 2013, it typically cost upward of $2.6 billion to formulate a medicine, test it in pre-clinical trials, and then advance it through the clinical trial process to attain regulatory approval for sale.